SCHEMBL2961711

SCHEMBL2961711

COC(=O)c1ccc(CC2(C(=O)O)CCCC2)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ ITGB1 P05556 1/20 0.41
▸ ITGA4 P13612 1/20 0.41
▸ HTT P42858 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ PPARG P37231 1/20 0.40
▸ PPARA Q07869 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ TSHR P16473 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ FFAR4 Q5NUL3 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2959644 0.84 KMT2A (0.42) KMT2AMEN1HTTSMN1; SMN2PPARG
SCHEMBL20482392 0.82 ALDH1A1 (0.51) KMT2AMEN1ITGB1ITGA4HTT
SCHEMBL2966606 0.82 LMNA (0.47) KMT2AMEN1HTTSMN1; SMN2GAA
SCHEMBL20482573 0.81 ITGB1 (0.46) KMT2AMEN1ITGB1ITGA4GAA
SCHEMBL20482676 0.77 SMPD1 (0.52) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL27585681 0.76 PDE4A (0.52) POLB
SCHEMBL5503225 0.76 PPARG (0.51) KMT2AMEN1HTTSMN1; SMN2PPARG
SCHEMBL2889364 0.75 GAA (0.64) HTTSMN1; SMN2PPARGPPARAGAA
SCHEMBL6626906 0.75 ALDH1A1 (0.48) KMT2AITGB1ITGA4HTTSMN1; SMN2
SCHEMBL2968013 0.75 PPARG (0.52) KMT2AMEN1HTTSMN1; SMN2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1445249-B1 NOVEL BENSOPHENONE DERIVATIVES OR SALTS THEREOF TOYAMA CHEMICAL CO LTD (JP) 2012-11-07 — — EP disclosed
US-7772285-B2 Benzophenone derivatives or salts thereof TOYAMA CHEMICAL CO., LTD. (JP) 2010-08-10 — — US disclosed
US-20050113400-A1 Inhibitors of transcription factor AP-1; autoimmune diseases; rheumatoid arthritis; high safety and excellent pharmacokinetics in vivo SHUNICHI SHIOZAWA (JP) 2005-05-26 — — US disclosed
EP-1445249-A1 NOVEL BENSOPHENONE DERIVATIVES OR SALTS THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2004-08-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113400-A1 Inhibitors of transcription factor AP-1; autoimmune diseases; rheumatoid arthritis; high safety and excellent pharmacokinetics in vivo SP1, AP1G1, JUN KMT2A 1394/4885MEN1 3908/4885ITGB1 3666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback